These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4672880)

  • 21. Immunological studies in patients with Crohn's disease.
    MacPherson BR; Albertini RJ; Beeken WL
    Gut; 1976 Feb; 17(2):100-6. PubMed ID: 1261880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of zinc status and malnutrition on immunological function in Crohn's disease.
    Ainley C; Cason J; Slavin BM; Wolstencroft RA; Thompson RP
    Gastroenterology; 1991 Jun; 100(6):1616-25. PubMed ID: 1902189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Selected cellular immunity parameters in patients with Lesniowski-Crohn disease].
    Słotwiński R; Szczygieł B; Lech G; Kolewska D; Wasik M
    Pol Merkur Lekarski; 1997 Nov; 3(17):224-7. PubMed ID: 9523477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte transformation in the mesenteric lymph nodes of patients with Crohn's disease.
    Guillou PJ; Brennan TG; Giles GR
    Gut; 1973 Jan; 14(1):20-4. PubMed ID: 4692250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic reactivity in rheumatoid arthritis. Response to mitogens.
    Lance EM; Knight SC
    Arthritis Rheum; 1974; 17(5):513-20. PubMed ID: 4278136
    [No Abstract]   [Full Text] [Related]  

  • 26. Human leucocyte antigens in Crohn's disease and ulcerative colitis.
    Gleeson MH; Walker JS; Wentzel J; Chapman JA; Harris R
    Gut; 1972 Jun; 13(6):438-40. PubMed ID: 5040832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of cell-mediated immunity in patients with Crohn's disease.
    Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
    Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
    Goodacre RL; Bienenstock J
    Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular immunity in Crohn's disease.
    Kraft SC
    Gastroenterology; 1971 Oct; 61(4):545-8. PubMed ID: 4939936
    [No Abstract]   [Full Text] [Related]  

  • 30. Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.
    Sieber G; Herrmann F; Zeitz M; Teichmann H; Rühl H
    Gut; 1984 Nov; 25(11):1255-61. PubMed ID: 6238880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of different target cells to the killing action of peripheral lymphocytes stimulated by autologous lymphoblastoid cell lines.
    Svedmyr EA; Deinhardt F; Klein G
    Int J Cancer; 1974 Jun; 13(6):891-903. PubMed ID: 4854235
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune status in healthy relatives of patients with familial Crohn's disease.
    Van Gossum A; Dupont E; Schandene L; Cremer M; Wybran J
    Dig Dis Sci; 1988 Aug; 33(8):945-50. PubMed ID: 2968901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immune defect syndrome in Crohn's disease (author's transl)].
    Kleesiek K; Masseck E; Pusztai-Markos Z; Spölgen W; Raguse T; Bräcker HP
    Klin Wochenschr; 1978 Dec; 56(24):1217-24. PubMed ID: 153428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte transformation and delayed hypersensitivity in Crohn's disease.
    Röpke C
    Scand J Gastroenterol; 1972; 7(7):671-7. PubMed ID: 4640058
    [No Abstract]   [Full Text] [Related]  

  • 35. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
    Selby WS; Jewell DP
    Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for immune reactivity against neoplasms.
    McKhann CF; Jagarlamoody SM
    Transplant Rev; 1971; 7():55-77. PubMed ID: 4112673
    [No Abstract]   [Full Text] [Related]  

  • 37. The immune competence of patients with inflammatory bowel disease.
    Bolton PM; James SL; Newcombe RG; Whitehead RH; Hughes LE
    Gut; 1974 Mar; 15(3):213-9. PubMed ID: 4841278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune status in Crohn's disease. 2. Originally unimpaired primary cell mediated immunity in vitro.
    Auer IO; Buschmann C; Ziemer E
    Gut; 1978 Jul; 19(7):618-26. PubMed ID: 150362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status.
    Magrath IT; Simon RM
    Int J Cancer; 1976 Oct; 18(4):399-408. PubMed ID: 977186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.